Pro-thrombotic Status in Patients with SARS-Cov-2 Infection (ATTAC-Co)
Patterns and Changes in Platelet Reactivity, Thrombotic Status and Endothelial Function in Hospitalized Patients with SARS-Cov-2 Infection
Sponsor: University Hospital of Ferrara
A NA clinical study on Severe Acute Respiratory Syndrome Coronavirus 2, this trial is completed. The trial is conducted by University Hospital of Ferrara and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2022 — Dec 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Oct 2021 — Dec 2022 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Recruiting NA
-
May 2020 — Jun 2020 [monthly]
Recruiting NA
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital of Ferrara
For direct contact, visit the study record on ClinicalTrials.gov .